News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Failed To Track Substandard Generics


2/27/2014 7:50:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The Food and Drug Administration has failed to monitor the effectiveness of generics that make up 80 percent of medicines sold in the U.S., according to doctors and researchers who said new regulatory efforts aren’t enough. Generic heart drugs made by some India-based companies don’t work as they should, said Preston Mason, a researcher at Brigham & Women’s Hospital in Boston who has studied the effectiveness of copies of Pfizer Inc. (PFE)’s Lipitor made in the U.S. and abroad. That may be because some companies are cutting corners to save money, he said.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Bloomberg
Read at Live Mint
Read at Forbes


comments powered by Disqus
Bloomberg
Live Mint
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES